omniture
TESSA THERAPEUTICS LTD

Latest News

Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study

82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPOR...

2021-04-30 18:00 1993

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a cl...

2021-02-10 19:51 1991

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a cl...

2021-02-10 19:12 1790

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinica...

2021-01-18 19:00 1792

Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer

BEDMINSTER, N.J. and SINGAPORE, Dec. 17, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinica...

2020-12-17 22:32 2800

Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma

SINGAPORE, Aug. 6, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy c...

2020-08-06 19:00 3100

Tessa Therapeutics Announces New Executive Leadership

SINGAPORE, May 5, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy co...

2020-05-05 00:00 2302

Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020

* State-of-the-art manufacturing facility will support clinical and commercial production of cell...

2019-12-19 20:00 1264